SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-11-000345
Filing Date
2011-07-07
Accepted
2011-07-07 15:40:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMD TO SCHED 13D FOR AEGERION PHARMACEUTICALS BY INDEX VENTURE ASSOC. III s13da_070711-aegerion.htm SC 13D/A 118622
  Complete submission text file 0000904454-11-000345.txt   120201
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 11956303
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ
Business Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ 441534605643
Index Venture Associates III Ltd (Filed by) CIK: 0001503683 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D/A